Fujifilm Diosynth Biotechnologies, a subsidiary of Japan’s Fujifilm Corp., has announced plans to spend more than $2 billion to build a new large-scale cell culture production site in the US to accelerate the growth of its biopharma CDMO business.
The biotech industry in Italy is vital and is showing a constant growth, report by Assobiotec and ENEA documents.
Rentschler Biopharma SE, headquartered in Laupheim, Germany, is a leading, family-owned, full-service biopharma CDMO. Owing to agile decision making and efficient processes, Rentschler Biopharma is the preferred outsourcing partner for bioprocess development, cGMP manufacturing, as well as elaboration of product approval strategies for over 150 clients worldwide.
Swiss chemical, pharmaceutical and life sciences companies help drive research around the world, and major players have research activities in the US, Singapore, Japan, as well as EU facilities in the United Kingdom and Germany. But do not underestimate the role of the domestic regional clusters and industrial sites.
With the cost pressures and time to market challenges that the health care industry faces, pharmaceutical and biotech companies must figure out ways to increase laboratory efficiency by managing its resources more effectively.
Virtually all areas of our lives would be inconceivable without products that come directly or indirectly in contact with chemical production: It affects the modern office environment, our private lives and thus our well-being and life fulfilment including health, leisure and personal protection.
